# Cross Country Healthcare share price (Cross Country Healthcare, Inc., CCRN)

> Cross Country Healthcare, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. CCRN · Healthcare · Medical Care Facilities · data as of 20 July 2026. Page: https://www.sectoralpha.in/us/stocks/ccrn

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting worse, from the last 12 quarters
- Price: $13.25 (+3.7% in a year)
- Revenue (Mar 2026): $241 M (−17.8% on a year ago)
- Profit (Mar 2026): −$4.3 M
- Operating margin: −0.8% (−1.3 points on a year ago)
- ROE: −29%, FY25
- ROIC: −0.4%, against a 7.1% cost of capital: −7.5 points
- Profit that came in as cash: 76%, last 3 years

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. ## What is the Cross Country Healthcare share price? Cross Country Healthcare, Inc.'s share price was $13.25 at the close on 20 July 2026. That is 23.1% above its average price over the last 200 trading days. In the last 52 weeks it traded between $8 and $14, and at that close it sat 84% of the way up from that low. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 21 weeks in a row. Over the last 1 year the share price moved +10% while the S&P 500 moved +19%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Cross Country Healthcare pay? Cross Country Healthcare, Inc. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Cross Country Healthcare on? Cross Country Healthcare is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Cross Country Healthcare profitable? Cross Country Healthcare, Inc. posted a net loss of $4.3 M in the Mar 2026 quarter. The full FY25 year was a loss of $94.9 M. That loss is 1.8% of the quarter's revenue. The same quarter a year earlier lost $490 K. 7 of the last 12 reported quarters were loss-making. ## How much revenue does Cross Country Healthcare make, and is it growing? Cross Country Healthcare, Inc. reported $241 M of revenue in the Mar 2026 quarter, −17.8% on the same quarter a year earlier. Over 4 years it has grown −11.0% a year on average. The last full year, FY25, came in at $1.1 B. The last four reported quarters add to $1.0 B. FY25 revenue was $1.1 B, −21.6% on the year before. Recent pace: the last four quarters grew −20.3% on average, against −11.0% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew −20.4%, against −24.9% a year over the last 8 quarters (accelerating). ## How much of every $100 of sales does Cross Country Healthcare keep? Cross Country Healthcare, Inc.'s operating margin was −0.8% in the Mar 2026 quarter, 1.3 percentage points lower than the same quarter a year ago. Across 5 years it has been between −0.1% and 9.9%. The latest quarter is below every full year in that period. Why the margin moved: operating margin changed −1.3 percentage points on the year while gross margin changed −0.3 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is Cross Country Healthcare's profit turning into cash? Over the last 3 years, 76% of Cross Country Healthcare, Inc.'s reported profit came in as cash from its operations, so most of the profit is real cash. In FY25 it brought in $48.3 M of operating cash against −$94.9 M of profit. After $8.2 M of spending on assets, $40.1 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Cross Country Healthcare's cash go? Cross Country Healthcare, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $30.8 M on assets over the last 3 years. Averaged over those years that is 1.0% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $30.8 M over the last 3 years. In short: most of the cash goes on covering the loss, not on new assets; spending on assets is small next to it. ## What is Cross Country Healthcare's P/E ratio, and how does it compare with its own history? Cross Country Healthcare, Inc. has no P/E right now, because its earnings are negative. The revenue and margin sections are where a turn would show first. Measured against sales instead, the market values Cross Country Healthcare, Inc. at 0.4× its FY25 revenue of $1.1 B. The P/E comes back here once profit turns positive. ## Is the Cross Country Healthcare business getting better or worse? Cross Country Healthcare, Inc.'s business is getting worse. Revenue, profit and EPS growth are shrinking: revenue growth is −20.4% in the latest quarter, against −5.1% at its best in 12 quarters, with ROCE steady at 0.9%. This is based on 12 quarters of 4 measures. Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind. ## How much does Cross Country Healthcare earn on its capital? Cross Country Healthcare, Inc. earned a ROE of −29% in FY25. Its return on capital used (ROIC) is 7.5 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a −9.0% net margin and 2.35× asset turnover (sales divided by assets). Why the return is what it is (FY25): a −9.0% net margin × 2.35× asset turnover × 1.39× leverage (assets divided by equity) ≈ −29.4% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: −0.4% − 7.1% = −7.5 percentage points. The 7.1% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The −0.4% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 0.9%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Cross Country Healthcare have too much debt? Cross Country Healthcare, Inc. has total debt of $2.0 M against shareholder equity of $313 M as of Mar 2026, so its debt is 0.01× its equity, which is very little. Year by year, that ratio went from 0.66 in FY21 to 0.01 in FY25. So the returns on this page come from the business, not from borrowed money. ## What is the Cross Country Healthcare shareholding pattern? 2.7% of Cross Country Healthcare, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 1.6 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Cross Country Healthcare from balance-sheet trouble? For Cross Country Healthcare, Inc., the Z-score is 4.80. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 4.80 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does Cross Country Healthcare rank in its industry? There is no score against its industry: Cross Country Healthcare, Inc. is not among the largest members shown in this industry comparison for Medical Care Facilities. The score ranks a company within its industry: each measure is scored against the other members. Without that group there is no score, so none is shown. ## Which companies is Cross Country Healthcare compared with? No sector comparison is shown here, not among the largest members shown in this industry comparison. ## Which companies are close to Cross Country Healthcare in size? Cross Country Healthcare is the 35th largest of 38 Medical Care Facilities companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: GMR Solutions Inc., The Oncology Institute, Inc. and Charming Medical. Just below it: Strata Critical Medical, Inc., Auna S.A. and Community Health Systems, Inc. ### Medical Care Facilities companies close in size

1. [GMR Solutions Inc.](https://www.sectoralpha.in/us/stocks/gmrs) $885 million
2. [The Oncology Institute, Inc.](https://www.sectoralpha.in/us/stocks/toi) $646 million
3. [Charming Medical Limited](https://www.sectoralpha.in/us/stocks/mcta) $504 million
4. Cross Country Healthcare, Inc. $428 million
5. [Strata Critical Medical, Inc.](https://www.sectoralpha.in/us/stocks/srta) $393 million
6. [Auna S.A.](https://www.sectoralpha.in/us/stocks/auna) $334 million
7. [Community Health Systems, Inc.](https://www.sectoralpha.in/us/stocks/cyh) $278 million

[All 38 Medical Care Facilities companies, largest first](https://www.sectoralpha.in/us/sectors/medical-care-facilities#all-companies)

### Companies close in size in other industries

1. [Allot Ltd.](https://www.sectoralpha.in/us/stocks/allt) $429 million · Software - Infrastructure
2. [Gladstone Capital Corporation](https://www.sectoralpha.in/us/stocks/glad) $429 million · Asset Management
3. Cross Country Healthcare, Inc. $428 million
4. [Summit Midstream Corporation](https://www.sectoralpha.in/us/stocks/smc) $427 million · Oil & Gas Midstream
5. [Columbus McKinnon Corporation](https://www.sectoralpha.in/us/stocks/cmco) $427 million · Farm & Heavy Construction Machinery

## What else do people ask about Cross Country Healthcare? ### What were Cross Country Healthcare's latest quarterly results? Cross Country Healthcare, Inc. reported revenue of $241 M and a net loss of $4.3 M for the Mar 2026 quarter. Earnings per share were −$0.14. The operating margin was −0.8%, 1.3 percentage points lower than a year earlier (as of 20 July 2026). ### What is Cross Country Healthcare's market cap? Cross Country Healthcare, Inc.'s market capitalisation is $428 M at a stock price of $13.25. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 20 July 2026). ### How is Cross Country Healthcare performing? Cross Country Healthcare, Inc.'s latest readings are below. Over the past 13 weeks it has done better than the S&P 500, for 21 weeks running. This describes what the data did, not a rating (as of 20 July 2026). ### Will Cross Country Healthcare's stock price go up? This page does not forecast Cross Country Healthcare, Inc.'s stock price. What it shows instead: the stock price is $13.25. Nobody can reliably say which way a price will move, and this site does not try (as of 20 July 2026). ### Where is Cross Country Healthcare in its business cycle? Cross Country Healthcare, Inc.'s FY25 operating margin was 0.2%, against a 5-year range of −0.1% to 9.9%: the low end of its own range, which is often where recoveries start. The latest quarter was −0.8%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 20 July 2026). ### What could break the Cross Country Healthcare story? Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 20 July 2026). ### Is Cross Country Healthcare a stock worth studying right now? What the numbers show: Cross Country Healthcare, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 20 July 2026). This is research, not advice. We’re not SEBI-registered.